银丹心脑通胶囊联合瑞舒伐他汀片治疗急性脑梗死患者的临床效果及对其神经功能、日常生活能力的影响

Clinical Effect of Yindan Xinnaotong Capsules Combined with Rosuvastatin Tablets in the Treatment of Patients with Acute Cerebral Infarction and the Influence on Neurological Function and Daily Living Ability

目的探讨银丹心脑通胶囊联合瑞舒伐他汀片治疗急性脑梗死患者的临床效果及对其神经功能、日常生活能力的影响。方法选取2020年6月至2022年1月我院收治的103例急性脑梗死患者,随机分为对照组(51例)和观察组(52例)。对照组采用瑞舒伐他汀片治疗,观察组采用银丹心脑通胶囊联合瑞舒伐他汀片治疗。比较两组的治疗效果、神经功能及日常生活能力。结果观察组治疗总有效率为94.23%,高于对照组的78.43%(P<0.05)。治疗4个疗程后,观察组的NIHSS评分低于对照组,ADL评分高于对照组(P<0.05)。结论银丹心脑通胶囊联合瑞舒伐他汀片治疗急性脑梗死,可明显提升临床疗效,有效改善患者的神经功能和日常生活能力,值得临床推广。

Objective To explore the clinical effect of Yindan Xinnaotong capsules combined with rosuvastatin tablets in the treatment of patients with acute cerebral infarction and the influence on neurological function and daily living ability.Methods 103 patients with acute cerebral infarction admitted to our hospital from June 2020 to January 2022 were selected and randomly divided into control group(51 cases)and observation group(52 cases).The control group was treated with rosuvastatin tablets,and the observation group was treated with Yindan Xinnaotong capsules combined with rosuvastatin tablets.The treatment effect,neurological function and daily living ability of the two groups were compared.Results The total effective rate of treatment in the observation group was 94.23%,higher than 78.43% in the control group(P<0.05).After 4 courses of treatment,the NIHSS score of the observation group was lower than that of the control group,and the ADL score was higher that of the control group(P<0.05).Conclusions Yindan Xinnaotong capsules combined with rosuvastatin tablets in the treatment of acute cerebral infarction can significantly improve the clinical efficacy,effectively improve the neurological function and daily living ability of patients,which is worthy of clinical promotion.